NOVOLIN

Swiss trademark · 347227 · Word mark · In force

Register entry

Registration number
347227
Application number
03503/1986
Status
In force
Type
Word mark
Filed
Jun 3, 1986
Registered
Jul 23, 1986
Published
Aug 25, 1986
Protected until
Jun 3, 2036
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Antidiabetische Präparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 3, 2026

    Renewed

    Expiry date
    03.06.2026 → 03.06.2036

    Published in Swissreg on 03.03.2026

  2. Nov 16, 2021

    Agent’s address changed

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich → Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 16.11.2021

  3. Mar 16, 2016

    Renewed

    Published in Swissreg on 16.03.2016

  4. Aug 20, 2007

    Agent’s address changed

    Representative
    Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich → Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in the SOGC no. 159 of 20.08.2007

  5. Jul 24, 2006

    Agent entered

    Representative
    R.A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich → Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich

    Published in the SOGC no. 141 of 24.07.2006

  6. Apr 10, 2006

    Renewed

    Published in the SOGC no. 70 of 10.04.2006

  7. Apr 3, 1990

    Holder’s address changed

    Owner
    Novo Industri A/S, Novo Allé, DK- Bagsvaerd, Denmark → Novo-Nordisk A/S, Novo Allé, DK- Bagsvaerd, Denmark

    Published in the SOGC no. 65 of 03.04.1990

  8. Aug 25, 1986

    Registered

    Published in the SOGC no. 196 of 25.08.1986

Parties

Holder

Novo Nordisk A/S

Novo-Nordisk A/S

Novo Allé, DK- Bagsvaerd, DK

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.